SPHINGOSINE-1-PHOSPHATE RECEPTOR SUBTYPE 1: A NOVEL TARGET IN THE TREATMENT OF CHRONIC MIGRAINE

$1,280,232FY2021Defense Health AgencyDOD

Saint Louis University, Saint Louis MO

Investigators